NEW YORK, Aug. 24, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stryker Corporation ("Stryker" or the "Company") (NYSE: SYK). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/syk.
The investigation concerns whether Stryker and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On August 23, 2017, Stryker revealed that it had notified the U.S. Food and Drug Administration ("FDA") of its voluntary product recall of some of its Oral Care products that were distributed between July 2015 and August 2017. This recall followed a warning letter from the FDA that the Company received on July 17, 2017, describing potential for cross-contamination of Oral Care products manufactured by a third party on equipment shared with non-pharmaceutical products, and after reports of minor irritations and allergic reactions, Stryker ceased its business relationship with the third-party supplier. Stryker then advised its shareholders that based on the assessed impact of the abovementioned issues on sales and operating income, it now projects its full-year organic sales growth and adjusted net earnings per diluted share to be at the lower end of its previously stated ranges of 6.5% to 7.0% and $6.45 to $6.55, respectively. Following this news, Stryker stock has dropped as much as $7.81 per share, or 5.37%, during intraday trading on August 23, 2017.
If you are aware of any facts relating to this investigation, or purchased shares of Stryker, you can assist this investigation by visiting the firm's site: www.bgandg.com/syk. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.